Mitochondrial import inner membrane translocase subunit Tim8 A, also known as deafness-dystonia peptide or protein is an enzyme that in humans is encoded by the TIMM8Agene.[5][6][7] This translocase has similarity to yeast mitochondrial proteins that are involved in the import of metabolite transporters from the cytoplasm into the mitochondrial inner membrane. The gene is mutated in deafness-dystonia syndrome (or Mohr-Tranebjaerg syndrome; MTS/DFN-1) and it is postulated that MTS/DFN-1 is a mitochondrial disease caused by a defective mitochondrial protein import system.[7]
The TIMM8A gene is located on q arm of chromosome X in position 22.1 and spans 3,313 base pairs.[8] The gene produces an 11 kDa protein composed of 97 amino acids.[9][10] The structure shows resemblance to yeast translocase of the inner membrane (TIM) proteins with two conserved paired cysteine residue motifs.[11] The cysteine residues organize zinc ions for stability and control other interactions with proteins.[11]
The human TIMM8A gene codes for a translocase involved in the import and insertion of hydrophobic membrane proteins from the cytoplasm into the mitochondrial inner membrane.[8] It is also required for the transfer of beta-barrel precursors from the TOM complex to the sorting and assembly machinery (SAM complex) of the outer membrane. It acts as a chaperone-like protein that protects the hydrophobic precursors from aggregation and guide them through the mitochondrial intermembrane space. The TIMM8-TIMM13 complex mediates the import of proteins such as TIMM23, SLC25A12/ARALAR1 and SLC25A13/ARALAR2, while the predominant TIMM9-TIMM10 70 kDa complex mediates the import of much more proteins. TIMM8A has been implicated as a required element in normal neurologic development.[12]
Mutation of TIMM8A is associated with Mohr-Tranebjaerg syndrome or deafness-dystonia syndrome, a mitochondrial disease postulated to be associated with a defective mitochondrial protein import system. [7]Mohr-Tranebjaerg syndrome is a recessive, X-linked neurodegenerative syndrome characterized by early-onset deafness followed by progressive dystonia in adulthood, progressive sensorineural hearing loss, mental retardation, dysphagia, paranoia, and optic atrophy.[13][14] It is known to be caused by a truncation or deletion of the 11 kDa protein product of TIMM8A.[15] Defects in this gene also cause Jensen syndrome, an X-linked disease with opticoacoustic nerve atrophy and muscle weakness.[8]
TIMM8A has been shown to interact with Signal transducing adaptor molecule[11] and TIMM13.[23][24] Three copies of TIMM8A and three copies of TIMM13 assemble to form a 70 kDa TIMM8-TIMM13 Complex with heterohexamer structure in the intermembrane space.[24][12] The TIMM8-TIMM13 Complex associates with the TIM22 complex whose core is composed of TIMM22 to import and assemble inner membrane proteins.[12]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Jin H, Kendall E, Freeman TC, Roberts RG, Vetrie DL (November 1999). "The human family of Deafness/Dystonia peptide (DDP) related mitochondrial import proteins". Genomics. 61 (3): 259–67. doi:10.1006/geno.1999.5966. PMID10552927.
^Jin H, May M, Tranebjaerg L, Kendall E, Fontán G, Jackson J, et al. (October 1996). "A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and optic atrophy". Nature Genetics. 14 (2): 177–80. doi:10.1038/ng1096-177. PMID8841189. S2CID22065091.
^ abcBlackstone C, Roberts RG, Seeburg DP, Sheng M (May 2003). "Interaction of the deafness-dystonia protein DDP/TIMM8a with the signal transduction adaptor molecule STAM1". Biochemical and Biophysical Research Communications. 305 (2): 345–52. doi:10.1016/S0006-291X(03)00767-8. PMID12745081.
^ abUjike H, Tanabe Y, Takehisa Y, Hayabara T, Kuroda S (June 2001). "A family with X-linked dystonia-deafness syndrome with a novel mutation of the DDP gene". Archives of Neurology. 58 (6): 1004–7. doi:10.1001/archneur.58.6.1004. PMID11405816.
^Swerdlow RH, Wooten GF (October 2001). "A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome". Annals of Neurology. 50 (4): 537–40. doi:10.1002/ana.1160. PMID11601506. S2CID28334892.
^Dulski J, Schinwelski M, Mandat T, Pienczk-Ręcławowicz K, Sławek J (2016). "Long-Term Follow-Up with Video of a Patient with Deafness-Dystonia Syndrome Treated with DBS-GPi". Stereotactic and Functional Neurosurgery. 94 (2): 123–5. doi:10.1159/000445078. PMID27100856. S2CID46846035.
^Shaker M, Lorigiano TH, Vadlamudi A (June 2016). "Xq22.1 contiguous gene deletion syndrome of X-linked agammaglobulinemia and Mohr-Tranebjærg syndrome". Annals of Allergy, Asthma & Immunology. 116 (6): 578–9. doi:10.1016/j.anai.2016.03.014. PMID27048950.
^Aguirre LA, Pérez-Bas M, Villamar M, López-Ariztegui MA, Moreno-Pelayo MA, Moreno F, del Castillo I (December 2008). "A Spanish sporadic case of deafness-dystonia (Mohr-Tranebjaerg) syndrome with a novel mutation in the gene encoding TIMM8a, a component of the mitochondrial protein translocase complexes". Neuromuscular Disorders. 18 (12): 979–81. doi:10.1016/j.nmd.2008.09.009. PMID18952432. S2CID27598478.
^Aguirre LA, del Castillo I, Macaya A, Medá C, Villamar M, Moreno-Pelayo MA, Moreno F (February 2006). "A novel mutation in the gene encoding TIMM8a, a component of the mitochondrial protein translocase complexes, in a Spanish familial case of deafness-dystonia (Mohr-Tranebjaerg) syndrome". American Journal of Medical Genetics. Part A. 140 (4): 392–7. doi:10.1002/ajmg.a.31079. PMID16411215. S2CID27887064.
^Kreisel SH, Binder J, Wöhrle JC, Krauss JK, Hofmann S, Bauer MF, et al. (October 2004). "Dystonia in the Mohr-Tranebjaerg syndrome responds to GABAergic substances". Movement Disorders. 19 (10): 1241–3. doi:10.1002/mds.20150. PMID15390009. S2CID31590188.
Swerdlow RH, Juel VC, Wooten GF (2003). "Dystonia with and without deafness is caused by TIMM8A mutation". Advances in Neurology. 94: 147–54. PMID14509668.
Vorechovský I, Vetrie D, Holland J, Bentley DR, Thomas K, Zhou JN, et al. (June 1994). "Isolation of cosmid and cDNA clones in the region surrounding the BTK gene at Xq21.3-q22". Genomics. 21 (3): 517–24. doi:10.1006/geno.1994.1310. PMID7959728.
Nakane T, Inada Y, Ito F, Itoh N, Tazawa S, Chiba S (July 2000). "Cloning and expression of mouse deafness dystonia peptide 1 cDNA". Biochemical and Biophysical Research Communications. 273 (2): 759–64. doi:10.1006/bbrc.2000.3004. PMID10873677.
Tranebjaerg L, Jensen PK, Van Ghelue M, Vnencak-Jones CL, Sund S, Elgjo K, et al. (December 2001). "Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene". Ophthalmic Genetics. 22 (4): 207–23. doi:10.1076/opge.22.4.207.2220. PMID11803487. S2CID19585131.